| | | Sec. 5. 24-A MRSA §4302, sub-§2, as enacted by PL 1995, c. 673, Pt. C, | | §1 and affected by §2, is amended to read: |
|
| | | 2. Plan complaint; adverse decisions; prior authorization | | statistics. A carrier shall provide annually to the | | superintendent information for each health plan that it offers on | plan complaints, adverse decisions and, prior authorization | | statistics and uniform quality data. This statistical | | information must contain, at a minimum: |
|
| | | A. The ratio of the number of complaints received by the | | plan to the total number of enrollees, reported by type of | | complaint and category of enrollee; |
|
| | | B. The ratio of the number of adverse decisions issued by | | the plan to the number of complaints received, reported by | | category; |
|
| | | C. The ratio of the number of prior authorizations denied | | by the plan to the number of prior authorizations requested, | | reported by category; |
|
| | | D. The ratio of the number of successful enrollee appeals | | to the total number of appeals filed; |
|
| | | E. The percentage of disenrollments by enrollees and | | providers from the health plan within the previous 12 months | | and the reasons for the disenrollments. With respect to | | enrollees, the information provided in this paragraph must | | differentiate between voluntary and involuntary | disenrollments; and |
|
| | | F. Enrollee satisfaction statistics, including provider-to- | | enrollee ratio by geographic region and medical specialty | | and a report on what actions, if any, the carrier has taken | | to improve complaint handling and eliminate the causes of | valid complaints.; |
|
| | | G.__Data on aggregate utilization of health care services by | | enrollees; |
|
| | | H.__Data on the demographic characteristics of enrollees; |
|
| | | I.__Data on disease-specific and age-specific mortality | | rates and, to the extent feasible, disease-specific and age- | | specific morbidity rates of enrollees; and |
|
| | | J.__Data on quality indicators and health outcomes, | | including, to the extent feasible and appropriate, data on | | pediatric cases and on a gender-specific basis. |
|
|